MicroRNA (miR)-128-3p inhibits the stem-like cell characteristics of breast cancer stem cells (BCSCs) by inhibiting the Wnt signaling pathway via downregulating NEK2, creating a new target for breast cancer treatment [21]. The gene discussed is NEK2; the disease is breast carcinoma.